Table 5.
Association Between the Presence of Splenomegaly and Laboratory Measurements of Liver Health
| Investigation | Splenomegaly | No Splenomegaly | z Statistic | P Value | ||
|---|---|---|---|---|---|---|
| No. | Median (IQR) | No. | Median (IQR) | |||
| APRI (<0.7) | 15 | 0.4 (0.4–0.6) | 36 | 0.4 (0.4–0.6) | −0.796 | 0.4 |
| ALT (10–45) | 20 | 37.5 (30.0–42.0) | 42 | 38.0 (30.0–44.0) | 0.226 | 0.8 |
| AST (15–40) | 15 | 36.0 (32.0–41.0) | 41 | 40.0 (35.0–52.0) | 2.398 | 0.02 |
| GGT (12–33) | 18 | 57.0 (35.0–85.0) | 39 | 42.0 (29.0–58.0) | −1.700 | 0.09 |
| Bilirubin (2–17) | 18 | 9.5 (5.0–12.0) | 29 | 9.0 (7.0–11.0) | −0.099 | 0.9 |
| Alkaline phosphatase (130–525) | 20 | 170.0 (154–206) | 39 | 217.0 (182–237) | 2.402 | 0.02 |
| Platelets (180–440) | 19 | 164.0 (137–235) | 39 | 220.0 (194–266) | 1.939 | 0.05 |
| Albumin (37–56) | 20 | 43.0 (38.5–47.5) | 37 | 46.0 (43.0–48.0) | 1.703 | 0.09 |
ALT indicates alanine aminotransferase; APRI, aspartate transaminase to platelet ratio index; AST, aspartate aminotransferase; GGT, gamma‐glutamyl transferase; IQR, interquartile range.